Treos Bio Presents New Translational Data Showing PolyPEPI1018 Plus Anti-PD-L1 Immunotherapy Remodels the Tumor Immune Microenvironment in MSS Colorectal Cancer

Summary

Treos Bio presented translational data at ESMO GI showing that PolyPEPI1018 combined with anti-PD-L1 immunotherapy increases CD8+ T-cell infiltration and PD-L1 expression in the tumor microenvironment of MSS colorectal cancer, with expansion of tumor-reactive TCR clonotypes.